Loading insider details...
Beta
Latest Form 4 (Apr 9, 2026): Grant/Award of 8,789 OVID shares, $22.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 9, 2026 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 8,789 | $22.5K |
| Mar 2, 2026 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 65,000 | n/a |
| Jun 18, 2025 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 45,000 | n/a |
| Dec 16, 2024 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 90,000 | n/a |
| Feb 26, 2024 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 30,000 | n/a |
| Feb 27, 2023 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 15,000 | n/a |
| Apr 12, 2022 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 69,424 | n/a |
| Feb 5, 2022 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 15,000 | n/a |
| Jun 12, 2021 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 15,000 | n/a |
| May 19, 2021 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 1,750 | n/a |